Chronic Migraines and Neurofdeeback Mindfulness
- Conditions
- Chronic Migraine, Headache
- Registration Number
- NCT06342219
- Lead Sponsor
- University of Saskatchewan
- Brief Summary
As the second phase of our study on migraine headaches and neurofeedback mindfulness, we will explore how chronic migraineurs will benefit from a long term practice (8 weeks) of neurofeedback mindfulness compared to a similar attention group and a waitlisted group. This randomized controlled trial will also explore if migrianuers could decrease their dependence on medicine intake after completion of the study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 135
- have a diagnosis of chronic migraine from a clinician or have met the criteria for a chronic migraine diagnosis based on ICHD-3
- reside in Saskatoon area
- have a smartphone and internet connection for accessing the MUSE app
- have no frequent background experience of meditation
- Comorbidity of Raynaud's syndrome or diabetes
- Current use of a preventative migraine treatment over 6 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Migraine Disability 8 weeks measured by Migraine Disability Assessment Scale (MIDAS)
Migraine Severity 8 weeks measured by Headache Impact Test-short form (HIT-6)
Dependence on medicine 8 weeks measured by Severity of Dependence Scale (SDS)
Headache management self-efficacy 8 weeks measured by Headache Management Self-Efficacy Scale
- Secondary Outcome Measures
Name Time Method Anxiety 8 weeks measured by BECK Anxiety Inventory (BAI)
Depression 8 weeks measured by The Center for Epidemiologic Studies Depression (CES-D)
Trial Locations
- Locations (1)
University of Saskatchewan
🇨🇦Saskatoon, Saskatchewan, Canada
University of Saskatchewan🇨🇦Saskatoon, Saskatchewan, Canada